Biological E’s Corbevax safe and immunogenic in five to 18 age group EP News Bureau Nov 4, 2022 The phase-II/III clinical trial results have been published in peer-reviewed and international journal 'Vaccine'
EMA recommends Moderna’s updated Omicron-tailored vaccine Reuters Oct 20, 2022 The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months
Hong Kong approves baby version of BioNTech vaccine for toddlers Reuters Oct 14, 2022 The government has said that each shot contains one-tenth of the adult dosage, reducing the chance of side effects
Bharat Biotech seeks drug regulator’s nod for Incovacc’s phase-III study in five-18 age… Press Trust of India Sep 12, 2022 Incovacc is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein
Pfizer-BioNTech COVID shot 73.2 per cent effective in kids aged under five years, reveals new data Reuters Aug 24, 2022 The updated data released yesterday showed 13 children had COVID-19, at least seven days after receiving a third dose of the…
Canada OKs Pfizer COVID booster for kids aged five-11 years Reuters Aug 22, 2022 The authorisation for a booster shot was granted after a thorough, independent review of the vaccine, which "provides good…
Australia provisionally approves Moderna’s COVID shot for children aged below five years Reuters Jul 19, 2022 So far, the shot was provisionally approved in the country for individuals aged six years and older and as a booster dose for…
Pfizer/BioNTech say three COVID shots elicit good response in children under five years of age Reuters May 25, 2022 The companies said they plan to soon ask global regulators to authorise the shot for the age group, children for whom no vaccine…
Biological E reduces Corbevax price to Rs 250 a dose EP News Bureau May 16, 2022 The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12…
Moderna completes FDA submission for use of COVID shot in adolescents, kids Reuters May 12, 2022 The company is seeking approval for the use of its vaccines in three distinct age groups - adolescents aged 12 to 17 years,…